Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)

1 This Regulation lays down implementing rules for the listed diseases referred to in Article 9(1)(a), (b) and (c) of Regulation (EU) 2016/429 of animals, as regards the disease-free and non-vaccination status of certain Member States or zones or compartments thereof, and the approval of eradication programmes for those listed diseases.

2 The Annexes to this Regulation list both the Member States or zones or compartments thereof whose disease-free status or eradication programmes shall be deemed to be approved as provided for in Article 280 of Regulation (EU) 2016/429, and those whose disease-free status and eradication programmes shall be duly approved by this Regulation and also duly listed in the Annexes thereto.

3 This Regulation lists in the Annexes thereto: (a) the Member States or zones or compartments thereof with approved compulsory eradication programmes for Category B diseases and optional eradication programmes for Category C diseases. (b) the Member States or zones thereof with approved disease-free status and non-vaccination status; (c) the compartments of Member States with recognised disease-free status.

1 The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations shall be listed in Chapter 1 of Part I of Annex I.

2 The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations shall be listed in Chapter 2 of Part I of Annex I.

3 The Member States or zones thereof with an approved compulsory eradication programme for infection with Brucella abortus, B. melitensis and B. suis shall be listed in Part II of Annex I.

1 The Member States or zones thereof with disease-free status from infection with Mycobacterium tuberculosis complex (Mycobacterium bovis, M.caprae and M. tuberculosis) (MTBC) shall be listed in Part I of Annex II.

2 The Member States or zones thereof with an approved compulsory eradication programme for infection with MTBC shall be listed in Part II of Annex II.

1 The Member States or zones thereof with disease-free status from infection with rabies virus (RABV) shall be listed in Part I of Annex III.

2 The Member States or zones thereof with an approved compulsory eradication programme for infection with RABV shall be listed in Part II of Annex III.

1 The Member States or zones thereof with disease-free status from enzootic bovine leukosis (EBL) shall be listed in Part I of Annex IV.

2 The Member States or zones thereof with an approved optional eradication programme for EBL shall be listed in Part II of Annex IV.

1 The Member States or zones thereof with disease-free status from infectious bovine rinotracheitis/infectious pustular vulvovaginitis (IBR/IPV) shall be listed in Part I of Annex V.

2 The Member States or zones thereof with an approved optional eradication programme for IBR/IPV shall be listed in Part II of Annex V.

1 The Member States or zones thereof with disease-free status from infection with Aujeszky’s disease virus (ADV) shall be listed in Part I of Annex VI.

2 The Member States or zones thereof with an approved optional eradication programme for infection with ADV shall be listed in Part II of Annex VI.

1 The Member States or zones thereof with disease-free status from Bovine viral diarroea (BVD) shall be listed in Part I of Annex VII.

2 The Member States or zones thereof with an approved optional eradication programme for infection with BVD shall be listed in Part II of Annex VII.

1 The Member States or zones thereof with disease-free status from infection with bluetongue virus (serotypes 1-24) (infection with BTV) shall be listed in Part I of Annex VIII.

2 The Member States or zones thereof with an approved optional eradication programme for infection with BTV shall be listed in Part II of Annex VIII.

The Member States or zones thereof with disease-free status from infestation with Varroa spp. shall be listed in Annex IX.

The Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination shall be listed in Annex X.

Compartments of the Member States free from HPAI shall be listed in Annex XI.

1 The following shall be listed in Part I of Annex XII: (a) Member States where their whole territory has disease-free status from viral haemorrhagic septicaemia (VHS); (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and (c) zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2 The following shall be listed in Part II of Annex XII: (a) Member States where their whole territory has an approved eradication programme for VHS; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS; and (c) zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

1 The following shall be listed in Part I of Annex XIII: (a) Member States where their whole territory has disease-free status from infectious haematopoietic necrosis (IHN); (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN; and (c) zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2 The following shall be listed in Part II of Annex XIII: (a) Member States where their whole territory has an approved eradication programme for IHN; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and (c) zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

1 The following shall be listed in Part I of Annex XIV: (a) Member States where their whole territory has disease-free status from infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV); (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and (c) zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2 The following shall be listed in Part II of Annex XIV: (a) Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and (c) zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

1 The following shall be listed in Part I of Annex XV: (a) Member States where their whole territory has disease-free status from infection with Marteilia refringens; (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and (c) zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2 The following shall be listed in Part II of Annex XV: (a) Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and (c) zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

1 The following shall be listed in Part I of Annex XVI: (a) Member States where their whole territory has disease-free status from infection with Bonamia exitiosa; (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and (c) zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2 The following shall be listed in Part II of Annex XVI: (a) Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and (c) zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

1 The following shall be listed in Part I of Annex XVII: (a) Member States where their whole territory has disease-free status from infection with Bonamia ostreae; (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and (c) zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2 The following shall be listed in Part II of Annex XVII: (a) Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and (c) zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

1 The following shall be listed in Part I of Annex XVIII: (a) Member States where their whole territory has disease-free status from infection with white spot syndrome virus (WSSV); (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and (c) zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2 The following shall be listed in Part II of Annex XVIII: (a) Member States where their whole territory has an approved eradication programme for infection with WSSV; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and (c) zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

The following acts are repealed: Decision 93/52/EEC, Decision 94/963/EC, Decision 95/98/EC, Decision 2003/467/EC, Decision 2004/558/EC, Decision 2008/185/EC, Decision 2009/177/EC, Regulation (EC) No 616/2009, Implementing Decision 2013/503/EU.

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union. It shall apply from 21 April 2021.